Clinical consequences of off-label reduced dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis

OBJECTIVE: Postmarketing observational studies report that a substantial percentage of patients with atrial fibrillation (AF) receive a reduced non-vitamin K antagonist oral anticoagulant (NOAC) dose without a clear indication. Recently, increasing evidence has become available to explore the clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Joosten, Linda P T, van Maanen, Rosanne, van den Dries, Carline J, Rutten, Frans H, Hoes, Arno W, Granger, Christopher B, Hemels, Martin E W, Geersing, Geert-Jan, van Doorn, Sander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410991/
https://www.ncbi.nlm.nih.gov/pubmed/37169490
http://dx.doi.org/10.1136/openhrt-2022-002197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410991/
https://www.ncbi.nlm.nih.gov/pubmed/37169490
http://dx.doi.org/10.1136/openhrt-2022-002197

Ejemplares similares